Pharma Franchise Company in Andhra Pradesh

We are offering PCD Franchise Andhra Pradesh to our clients.

We are offering PCD Pharma Franchisee in Andhra Pradesh.

We are a KARNAL based pharmaceutical company dealing into multi-dimensional range of pharmaceutical products. We are looking for Pharma PCD / Franchise in Andhra Pradesh State for the following districts:

 

1)PCD Pharma Franchise on monopoly basis in Adilabad
2) PCD Pharma Franchise on monopoly basis in YSR
3) PCD Pharma Franchise on monopoly basis in Khammam
4) PCD Pharma Franchise on monopoly basis in Krishna
5) PCD Pharma Franchise on monopoly basis in Mahbubnagar
6) PCD Pharma Franchise on monopoly basis in Medak
7) PCD Pharma Franchise on monopoly basis in Nalgonda
8) PCD Pharma Franchise on monopoly basis in Nellore
9) PCD Pharma Franchise on monopoly basis in Prakasam
10) PCD Pharma Franchise on monopoly basis in Rangareddy
11) PCD Pharma Franchise on monopoly basis in Srikakulam
12) PCD Pharma Franchise on monopoly basis in Visakhapatnam

13) PCD Pharma Franchise on monopoly basis in Vizianagar

 

Advantages of being Franchise of ASTEMAX BIOTECH.

• The company has more than 1000 products in 5 Divisions and adding more according to market demand.
• All products are Excise duty-free.
• The Company is ISO 9001:2008 Certified Productions are in GMP Certified units.
• Company Provides Sample, Visual Aids, LBL, Reminder cards, Visiting card, Order books, MR bags, ASM Bags, Pads, Gift articles for better penetration in the market.
• The company also provides Product Manual, Product information updates to keep its associates (Franchise) well informed.
• Advertisement support in Leading Medical Journals, Medical Indexes like IDR, CIMS, Drug Today, Drug Index, Drug Update, Medicine Update, ADR etc.
• Annual Target Incentives.
• Monthly Promotional Schemes.
• Order Execution in 24 Hours.
• Every month Gift For Doctors
• The company understands new demands of market introduces new molecules every month to help associates to grow faster and deeper in a market.